Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview
Tóm tắt
Từ khóa
Tài liệu tham khảo
Berger AM, Kilroy TJ . Adverse effects of treatment; oral complications. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer; Principles and Practice of Oncology, 5th edn Lippincott-Raven Publishers: Philadelphia 1997 2714–2725
Schubert MM, Williams BE, Lloid ME et al. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index Cancer 1992 69: 2469–2477
Woo SB, Sonis ST, Monopoli MM, Sonis AL . A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients Cancer 1993 72: 1612–1617
Donnelly JP, Muus P, Schattenberg A et al. A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients Bone Marrow Transplant 1992 9: 409–413
Sonis ST . Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity Oral Oncol 1998 34: 39–43
Sleisenger MH, Fordtran JS . Gastrointestinal Disease; Pathophysiology, Diagnosis, Management, 4th edn WB Saunders Company: Philadelphia 1989
Sherman ML, Datta R, Hallahan DE et al. Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes J Clin Invest 1991 87: 1794–1797
Hoffmann B, Hintermeier-Knabe R, Holler E et al. Evidence for induction of TNFa by irradiation and cytotoxic therapy preceding bone marrow transplantation – in vivo and in vitro studies Eur Cytokine Netw 1992 3: 256
Ferrara JL . Cytokine dysregulation as a mechanism of graft versus host disease Curr Opin Immunol 1993 5: 794–799
Sonis ST, Tracey C, Shklar G et al. An animal model for mucositis induced by cancer chemotherapy Oral Surg Oral Med Oral Pathol 1990 69: 437–443
Schwaighofer H, Kernan NA, O'Reilly RJ et al. Serum levels of cytokines and secondary messages after T-cell-depleted and non-T-cell-depleted bone marrow transplantation: influence of conditioning and hematopoietic reconstitution Transplantation 1996 62: 947–953
Hill GR, Crawford JM, Cooke KR et al. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines Blood 1997 90: 3204–3213
Holler E, Kolb HJ, Moller A et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation Blood 1990 75: 1011–1016
Niederwieser D, Herold M, Woloszczuk W et al. Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages Transplantation 1990 50: 620–625
Holler E, Kolb HJ, Mittermuller J et al. Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F) Blood 1995 86: 890–899
Chasty RC, Lamb WR, Gallati H et al. Serum cytokine levels in patients undergoing bone marrow transplantation Bone Marrow Transplant 1993 12: 331–336
Schwaighofer H, Herold M, Schwarz T et al. Serum levels of interleukin 6, interleukin 8, and C-reactive protein after human allogeneic bone marrow transplantation Transplantation 1994 58: 430–436
Adams RB, Planchon SM, Roche JK . IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding J Immunol 1993 150: 2356–2363
Austgen TR, Chen MK, Dudrick PS et al. Cytokine regulation of intestinal glutamine utilization Am J Surg 1992 163: 174–179
Marano CW, Lewis SA, Garulacan LA et al. Tumor necrosis factor-alpha increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line J Membr Biol 1998 161: 263–274
Souba WW, Copeland EM . Cytokine modulation of Na(+)-dependent glutamine transport across the brush border membrane of monolayers of human intestinal Caco-2 cells Ann Surg 1992 215: 536–544
Jarry A, Muzeau F, Laboisse C . Cytokine effects in a human colonic goblet cell line. Cellular damage and its partial prevention by 5 aminosalicylic acid Dig Dis Sci 1992 37: 1170–1178
Fox PC, Grisius MM, Bermudez DK, Sun D . Cytokine mRNA expression in labial salivary glands and cytokine secretion in parotid saliva in Sjogren's syndrome Adv Exp Med Biol 1998 438: 909–915
Xun CQ, Thompson JS, Jennings CD et al. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice Blood 1994 83: 2360–2367
Goke M, Podolsky DK . Regulation of the mucosal epithelial barrier Baillieres Clin Gastroenterol 1996 10: 393–405
Wright NA . Aspects of the biology of regeneration and repair in the human gastrointestinal tract Philos Trans R Soc Lond B Biol Sci 1998 353: 925–933
Steel G . Combination of radiotherapy and chemotherapy. In Steel G (ed) Basic Clinical Radiobiology; for Radiation Oncologists Edward Arnold: London 1993 pp 151–162
Muus P, Donnelly P, Schattenberg A et al. Idarubicin-related side effects in recipients of T-cell-depleted allogeneic bone marrow transplants are schedule dependent Semin Oncol 1993 20: (Suppl. 8) 47–52
Shaw MT, Spector MH, Ladman AJ . Effects of cancer, radiotherapy and cytotoxic drugs on intestinal structure and function Cancer Treat Rev 1979 6: 141–151
McNabb PC, Tomasi TB . Host defense mechanisms at mucosal surfaces Annu Rev Microbiol 1981 35: 477–496
Mestecky J, Russell MW, Elson CO . Intestinal IgA: novel views on its function in the defence of the largest mucosal surface Gut 1999 44: 2–5
Garfunkel AA, Tager N, Chausu S et al. Oral complications in bone marrow transplantation patients: recent advances Isr J Med Sci 1994 30: 120–124
Meurman JH, Pyrhonen S, Teerenhovi L, Lindqvist C . Oral sources of septicaemia in patients with malignancies Oral Oncol 1997 33: 389–397
Ruescher TJ, Sodeifi A, Scrivani SJ et al. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies Cancer 1998 82: 2275–2281
Donnelly JP, Dompeling EC, Meis JF, de-Pauw BE . Bacteremia due to oral viridans streptococci in neutropenic patients with cancer: cytostatics are a more important risk factor than antibacterial prophylaxis Clin Infect Dis 1995 20: 469–470
Elting LS, Bodey GP, Keefe BH . Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors Clin Infect Dis 1992 14: 1201–1207
Lucas VS, Beighton D, Roberts GJ, Challacombe SJ . Changes in the oral streptococcal flora of children undergoing allogeneic bone marrow transplantation J Infect 1997 35: 135–141
Dompeling EC, Donnelly JP, Raemaekers JM, de-Pauw BE . Pre-emptive administration of corticosteroids prevents the development of ARDS associated with Streptococcus mitis bacteremia following chemotherapy with high-dose cytarabine Ann Hematol 1994 69: 69–71
Hall G, Heimdahl A, Nord CE . Bacteremia after oral surgery and antibiotic prophylaxis for endocarditis Clin Infect Dis 1999 29: 1–8
Gibson GR, Roberfroid MB . Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics J Nutr 1995 125: 1401–1412
Ferry DM, Butt TJ, Broom MF et al. Bacterial chemotactic oligopeptides and the intestinal mucosal barrier Gastroenterology 1989 97: 61–67
Tancrede CH, Andremont AO . Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies J Infect Dis 1985 152: 99–103
Guzman SG, Bonsack M, Liberty J, Delaney JP . Abdominal radiation causes bacterial translocation J Surg Res 1989 46: 104–107
Berg RD . Bacterial translocation from the gastrointestinal tracts of mice receiving immunosuppressive chemotherapeutic agents Curr Microbiol 1983 8: 285–292
Wells CL, Maddaus MA, Simmons RL . Proposed mechanisms for the translocation of intestinal bacteria Rev Infect Dis 1988 10: 958–979
Alexander JW, Boyce ST, Babcock GF et al. The process of microbial translocation Ann Surg 1990 212: 496–510
van-Leeuwen PA, Boermeester MA, Houdijk AP et al. Clinical significance of translocation Gut 1994 35: (Suppl.) S28–S34
O'Dwyer ST, Michie HR, Ziegler TR et al. A single dose of endotoxin increases intestinal permeability in healthy humans Arch Surg 1988 123: 1459–1464
Nestel FP, Price KS, Seemayer TA, Lapp WS . Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease J Exp Med 1992 175: 405–413
Jackson SK, Parton J, Barnes RA et al. Effect of IgM-enriched intravenous immunoglobulin (Pentaglobin) on endotoxaemia and anti-endotoxin antibodies in bone marrow transplantation Eur J Clin Invest 1993 23: 540–545
Schrijver IA, Melief MJ, Eulderink F et al. Bacterial peptidoglycan polysaccharides in sterile human spleen induce proinflammatory cytokine production by human blood cells J Infect Dis 1999 179: 1459–1468
Gomez L, Martino R, Rolston KV . Neutropenic enterocolitis: spectrum of the disease and comparison of definite and possible cases Clin Infect Dis 1998 27: 695–699
Pouwels MJ, Donnelly JP, Raemaekers JM et al. Clostridium septicum sepsis and neutropenic enterocolitis in a patient treated with intensive chemotherapy for acute myeloid leukemia Ann Hematol 1997 74: 143–147
Yuen KY, Woo PCY, Liang RHS et al. Clinical significance of alimentary tract microbes in bone marrow transplant recipients Diagn Microbiol Infect Dis 1998 30: 75–81
Berkowitz RJ, Strandjord S, Jones P et al. Stomatologic complications of bone marrow transplantation in a pediatric population Pediatr Dent 1987 9: 105–110
McDonald GB, Shulman HM, Sullivan KM, Spencer GD . Intestinal and hepatic complications of human bone marrow transplantation. Part II Gastroenterology 1986 90: 770–784
Lacy ER . Epithelial restitution in the gastrointestinal tract J Clin Gastroenterol 1988 10: (Suppl. 1) S72–S77
Moss SF, Wright NA . Molecular aspects of mucosal repair: a summary (comment) J Biol Med 1996 69: 155–158
Modlin IM, Poulsom R . Trefoil peptides: mitogens, motogens, or mirages? J Clin Gastroenterol 1997 25: (Suppl. 1) S94–S100
Podolsky DK . Healing the epithelium: solving the problem from two sides J Gastroenterol 1997 32: 122–126
Imamura M, Hashino S, Kobayashi H et al. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosisfactor-alpha in graft-versus-host disease Bone MarrowTransplant 1994 13: 745–751
Pollard M, Chang CF, Srivastava KK . The role of microflora in development of graft-versus-host disease Transplant Proc 1976 8: 533–536
van-Bekkum DW, Knaan S . Role of bacterial microflora in development of intestinal lesions from graft-versus-host reaction J Natl Cancer Inst 1977 58: 787–790
Beelen DW, Elmaagacil A, Müller K-D et al. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomised trial Blood 1999 93: 3267–3275
Travis S, Menzies I . Intestinal permeability: functional assessment and significance Clin Sci Colch 1992 82: 471–488
Johansson JE, Ekman T . Gastro-intestinal toxicity related to bone marrow transplantation: disruption of the intestinal barrier precedes clinical findings Bone Marrow Transplant 1997 19: 921–925
Selby P, McElwain TJ, Crofts M et al. 51Cr-EDTA test for intestinal permeability Lancet 1984 2: 38–39
Rohrbaugh TM, Anolik R, August CS et al. Absorption of oral aminoglycosides following bone marrow transplantation Cancer 1984 53: 1502–1506
Ranaldi G, Islam K, Sambuy Y . Epithelial cells in culture as a model for the intestinal transport of antimicrobial agents Antimicrob Agents Chemother 1992 36: 1374–1381
Meunier V, Bourrie M, Berger Y, Fabre G . The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications Cell Biol Toxicol 1995 11: 187–194
Uil JJ, van-Elburg RM, van-Overbeek FM et al. Clinical implications of the sugar absorption test: intestinal permeability test to assess mucosal barrier function Scand J Gastroenterol 1997 223: (Suppl.) 20–28
Parrilli G, Iaffaioli RV, Capuano G et al. Changes in intestinal permeability to lactulose induced by cytotoxic chemotherapy Cancer Treat Rep 1982 66: 1435–1436
Parrilli G, Iaffaioli RV, Martorano M et al. Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer Cancer Res 1989 49: 3689–3691
Keefe DM, Cummins AG, Dale BM et al. Effect of high-dose chemotherapy on intestinal permeability in humans Clin Sci Colch 1997 92: 385–389
Fegan C, Poynton CH, Whittaker JA . The gut mucosal barrier in bone marrow transplantation Bone Marrow Transplant 1990 5: 373–377
Bow EJ, Loewen R, Cheang MS, Schacter B . Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen Clin Infect Dis 1995 21: 361–369
Bow EJ, Loewen R, Cheang MS, Shore TB et al. Cytotoxic therapy-induced D-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia in adults J Clin Oncol 1997 15: 2254–2261
Sonis ST, Eilers JP, Epstein JB et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy Cancer 1999 85: 2103–2113
Saiki T, Mitsuyama K, Toyonaga A et al. Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease Scand J Gastroenterol 1998 33: 616–622
Wymenga AN, van-der-Graaf WT, Spijkervet FL et al. A new in vitro assay for quantitation of chemotherapy-induced mucositis Br J Cancer 1997 76: 1062–1066
Adkins D, Goodgold H, Hendershott L et al. Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients Bone Marrow Transplant 1997 19: 809–812
Deitch EA . Bacterial translocation: the influence of dietary variables Gut 1994 35: (Suppl.) S23–S27
Papadopoulou A, Williams MD, Darbyshire PJ, Booth IW . Nutritional support in children undergoing bone marrow transplantation Clin Nutr 1998 17: 57–63
Papadopoulou A, MacDonald A, Williams MD et al. Enteral nutrition after bone marrow transplantation Arch Dis Child 1997 77: 131–136
Ramos MG, Bambirra EA, Cara DC et al. Oral administration of short-chain fatty acids reduces the intestinal mucositis caused by treatment with Ara-C in mice fed commercial or elemental diets Nutr Cancer 1997 28: 212–217
Illig KA, Ryan CK, Hardy DJ et al. Total parenteral nutrition-induced changes in gut mucosal function: atrophy alone is not the issue Surgery 1992 112: 631–637
Weisdorf SA, Lysne J, Wind D et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation Transplantation 1987 43: 833–838
Iestra JA, Fibbe WE, Zwinderman AH et al. Parenteral nutrition following intensive cytotoxic therapy: an exploratory study on the need for parenteral nutrition after various treatment approaches for haematological malignancies Bone Marrow Transplant 1999 23: 933–939
Karatzas T, Scopa S, Tsoni I et al. Effect of glutamine on intestinal mucosal integrity and bacterial translocation after abdominal radiation Clin Nutr 1991 10: 199–205
Klimberg VS, Souba WW, Dolson DJ et al. Prophylactic glutamine protects the intestinal mucosa from radiation injury Cancer 1990 66: 62–68
Klimberg VS, Nwokedi E, Hutchins LF et al. Glutamine facilitates chemotherapy while reducing toxicity J Paren Ent Nutr 1992 16: (Suppl.) 83S–87S
Anderson PM, Ramsay NKC, Shu XO et al. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation Bone Marrow Transplant 1998 22: 339–344
Anderson PM, Schroeder G, Skubitz KM . Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy Cancer 1998 83: 1433–1439
Muscaritoli M, Micozzi A, Conversano L et al. Oral glutamine in the prevention of chemotherapy-induced gastrointestinal toxicity Eur J Cancer 1997 33: 319–320
Brown SA, Goringe A, Fegan C et al. Parenteral glutamine protects hepatic function during bone marrow transplantation Bone Marrow Transplant 1998 22: 281–284
Ziegler TR, Young LS, Benfell K et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study Ann Intern Med 1992 116: 821–828
Schloerb PR, Skikne BS . Oral and parenteral glutamine in bone marrow transplantation: A randomized, double-blind study JPEN 1999 23: 117–122
van-Zaanen HC, van-der-Lelie H, Timmer JG et al. Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity Cancer 1994 74: 2879–2884
Franzen L, Henriksson R, Littbrand B, Zackrisson B . Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebo-controlled study Acta Oncol 1995 34: 219–223
Makkonen TA, Bostrom P, Vilja P, Joensuu H . Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study Int J Radiat Oncol Biol Phys 1994 30: 177–182
Barker G, Loftus L, Cuddy P, Barker B . The effects of sucralfate suspension and diphenhydramine syrup plus kaolin-pectin on radiotherapy-induced mucositis Oral Surg Oral Med Oral Pathol 1991 71: 288–293
Sonis ST, Van-Vugt AG, Brien JP et al. Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis Oral Oncol 1997 33: 47–54
Sonis ST, Costa-JW J, Evitts SM et al. Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy Oral Surg Oral Med Oral Pathol 1992 74: 749–755
Gordon B, Spadinger A, Hodges E et al. Effect of granulocyte–macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation J Clin Oncol 1994 12: 1917–1922
Ibrahim EM, al-Mulhim FA . Effect of granulocyte–macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients Med Oncol 1997 14: 47–51
Lieschke GJ, Ramenghi U, O'Connor MP et al. Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation Br J Haematol 1992 82: 589–595
Keith-JC J, Albert L, Sonis ST et al. IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology Stem Cells 1994 12: (Suppl. 1) 79–89
Sonis ST, Van-Vugt AG, McDonald J et al. Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters Cytokine 1997 9: 605–612
Danilenko DM . Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor Toxicol Pathol 1999 27: 64–71
Reilly RM, Domingo R, Sandhu J . Oral delivery of antibodies. Future pharmacokinetic trends Clin Pharmacokinet 1997 32: 313–323
Barker GJ . Current practices in the oral management of the patient undergoing chemotherapy or bone marrow transplantation Support Care Cancer 1999 7: 17–20
Bondi E, Baroni C, Prete A et al. Local antimicrobial therapy of oral mucositis in paediatric patients undergoing bone marrow transplantation Oral Oncol 1997 33: 322–326
Ferretti GA, Ash RC, Brown AT et al. Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants J Am Dent Assoc 1987 114: 461–467
Foote RL, Loprinzi CL, Frank AR et al. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis J Clin Oncol 1994 12: 2630–2633
Weisdorf DJ, Bostrom B, Raether D et al. Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse Bone Marrow Transplant 1989 4: 89–95
Spijkervet FK, van-Saene HK, van-Saene JJ et al. Mucositis prevention by selective elimination of oral flora in irradiated head and neck cancer patients J Oral Pathol Med 1990 19: 486–489
Salminen S, Isolauri E, Salminen E . Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges Antonie Van Leeuwenhoek 1996 70: 347–358
Johansson JE, Ekman T . Gut mucosa barrier preservation by orally administered IgA-IgG to patients undergoing bone marrow transplantation: a randomised pilot study BoneMarrow Transplant 1999 24: 35–39